| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $360K | -10.3% |
| Cost of Revenue | $24K | -15.1% |
| Gross Profit | $336K | -9.9% |
| R&D Expense | $10.1M | +88.7% |
| SG&A Expense | $5.9M | -10.5% |
| Operating Income | -$15.6M | -35.4% |
| Pre-tax Income | -$14.2M | -58.1% |
| Net Income | -$14.2M | -58.6% |
| EPS (Basic) | -$1.58 | -36.2% |
| EPS (Diluted) | -$1.58 | -36.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | +175.8% |
| Short-term Investments | $1.4M | -85.8% |
| Accounts Receivable | $16K | -91.8% |
| Current Assets | $3.1M | -71.9% |
| Total Assets | $4.1M | -66.8% |
| Current Liabilities | $3.7M | -0.7% |
| Stockholders' Equity | $357K | -95.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.8M | -31.1% |
| Capital Expenditures | $116K | +9.3% |
| Investing Cash Flow | $8.9M | +1629.2% |
| Financing Cash Flow | $2.9M | -61.3% |
| Free Cash Flow | -$10.9M | -30.8% |